Angiogenic factor AGGF1 is a general splicing factor regulating angiogenesis and vascular development by alternative splicing of SRSF6
The FASEB Journal · 15.03.2025 · 39 (5)
DOI: 10.1096/fj.202403156r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 04.03.2025. Verfasst von Wenchao Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genomics, School of Biomedical Sciences, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, P. R. C…. Hauptthemen laut MEDLINE: Alternative Splicing, Serine-Arginine Splicing Factors, Neovascularization, Physiologic, Angiogenic Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: MOST | National Key Research and Development Program of China grant, NSFC | National Natural Science Foundation of China grant, Shandong First Medical University and Shandong Academy of Medical Sciences.
Abstract (Originalsprache)
AGGF1 encodes an angiogenic factor that causes vascular disease Klippel–Trenaunay syndrome when mutated. AGGF1 also acts at the top of the genetic regulatory hierarchy for mesodermal differentiation of hemangioblasts, multipotent stem cells for differentiation of blood cells and vascular cells. Alternative splicing (AS) is a post‐transcriptional process that generates multiple mature mRNAs from a single primary transcript (pre‐mRNA), producing protein diversity. Deregulation of AS leads to many human diseases. The physiological role and mechanism of AGGF1 in AS are not clear. Full‐length transcriptome sequencing of human pulmonary artery endothelial cells (HPAECs) with AGGF1 silencing revealed 63 121 genes, including 1144 new unannotated genes, and showed that AGGF1 is a general splicing factor regulating AS of 436 genes, including SRSF6 regulating AS of many target genes. AGGF1 promoted the skipping of exon 3 that produces the full‐length SRSF6 protein, an evolutionarily conserved AS event. Overexpression of full‐length SRSF6 reversed the reduced cell proliferation, migration, and capillary tube formation of HPAECs with AGGF1 silencing. Knockdown of SRSF6 and overexpression of the shorter, alternatively spliced isoform of SRSF6 both inhibited HPAEC proliferation, migration, and capillary tube formation, whereas opposite results were obtained for overexpression of full‐length SRSF6. Knockdown of srsf6 impaired development of ISVs in zebrafish, whereas overexpression of srsf6 enhanced vascular development and partially rescued impaired ISV development in zebrafish embryos with aggf1 knockdown. Overall, our findings reveal that AGGF1 is a general splicing factor, and that AGGF1‐mediated exon 3 skipping of SRSF6 pre‐mRNA is important for endothelial cell functions, angiogenesis, and vascular development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Genomics, School of Biomedical Sciences, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, P. R. China.
- Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Maternal and Child Health Hospital of Hubei Province, Women and Children's H…
- Department of Bioinformatics and Systems Biology, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, P. R.…
ORCID-Profile: Wenchao Lv, Jingwen Zhang, Dayin Lyu, Rui Zhang, Chengqi Xu, Kang Ning, Mian Li, Yan Zhao, Jinxiang Han, Qing K Wang
Förderung
- MOST | National Key Research and Development Program of China grant
- NSFC | National Natural Science Foundation of China grant
- Shandong First Medical University and Shandong Academy of Medical Sciences
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Lv, W., Zhang, J., Lyu, D., Zhang, R., Xu, C., Ning, K., Li, M., Zhao, Y., Han, J., & Wang, Q. K. (2025). Angiogenic factor AGGF1 is a general splicing factor regulating angiogenesis and vascular development by alternative splicing of SRSF6. The FASEB Journal, 39(5). https://doi.org/10.1096/fj.202403156r
Vancouver
Lv W, Zhang J, Lyu D, Zhang R, Xu C, Ning K, et al. Angiogenic factor AGGF1 is a general splicing factor regulating angiogenesis and vascular development by alternative splicing of SRSF6. The FASEB Journal. 2025;39(5). doi:10.1096/fj.202403156r
BibTeX
@article{Lv2025,
author = {Lv, Wenchao and Zhang, Jingwen and Lyu, Dayin and Zhang, Rui and Xu, Chengqi and Ning, Kang and Li, Mian and Zhao, Yan and Han, Jinxiang and Wang, Qing K},
title = {Angiogenic factor AGGF1 is a general splicing factor regulating angiogenesis and vascular development by alternative splicing of SRSF6},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {5},
doi = {10.1096/fj.202403156r}
}
EUVIMED